Bernhard Lampert

794 total citations
14 papers, 614 citations indexed

About

Bernhard Lampert is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Bernhard Lampert has authored 14 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Bernhard Lampert's work include Herpesvirus Infections and Treatments (5 papers), HIV/AIDS drug development and treatment (5 papers) and Poxvirus research and outbreaks (4 papers). Bernhard Lampert is often cited by papers focused on Herpesvirus Infections and Treatments (5 papers), HIV/AIDS drug development and treatment (5 papers) and Poxvirus research and outbreaks (4 papers). Bernhard Lampert collaborates with scholars based in United States and Belgium. Bernhard Lampert's co-authors include George R. Painter, Alice Robertson, Lawrence C. Trost, Wendy Painter, Merrick R. Almond, James T. Stewart, Scott A. Foster, Randall Lanier, Michelle Rose and R. Mark L. Buller and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.

In The Last Decade

Bernhard Lampert

14 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernhard Lampert United States 10 332 277 223 186 84 14 614
Elizabeth Wardrop Canada 10 166 0.5× 246 0.9× 211 0.9× 232 1.2× 65 0.8× 10 578
Carol Lackman-Smith United States 14 149 0.4× 330 1.2× 278 1.2× 307 1.7× 40 0.5× 22 791
Boris Feld United States 16 330 1.0× 56 0.2× 177 0.8× 197 1.1× 64 0.8× 26 724
Nobutoki Takamune Japan 18 125 0.4× 343 1.2× 346 1.6× 313 1.7× 28 0.3× 45 785
Ewald M. Wondrak United States 18 78 0.2× 635 2.3× 392 1.8× 605 3.3× 49 0.6× 24 947
Arthur Thornton United States 9 183 0.6× 376 1.4× 324 1.5× 221 1.2× 46 0.5× 11 829
Jianhui Guo United States 16 223 0.7× 732 2.6× 765 3.4× 499 2.7× 28 0.3× 29 1.2k
Dylan Harris United States 14 77 0.2× 250 0.9× 393 1.8× 227 1.2× 44 0.5× 15 594
Elcira C. Villarreal United States 15 320 1.0× 111 0.4× 168 0.8× 73 0.4× 69 0.8× 21 536
Paul W. Keller United States 10 107 0.3× 179 0.6× 250 1.1× 152 0.8× 59 0.7× 12 530

Countries citing papers authored by Bernhard Lampert

Since Specialization
Citations

This map shows the geographic impact of Bernhard Lampert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Lampert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Lampert more than expected).

Fields of papers citing papers by Bernhard Lampert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Lampert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Lampert. The network helps show where Bernhard Lampert may publish in the future.

Co-authorship network of co-authors of Bernhard Lampert

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Lampert. A scholar is included among the top collaborators of Bernhard Lampert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Lampert. Bernhard Lampert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Painter, Wendy, et al.. (2012). First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses. Antimicrobial Agents and Chemotherapy. 56(5). 2726–2734. 124 indexed citations
2.
3.
Lanier, E. Randall, et al.. (2011). CMX001 (Hexadecyloxypropyl Cidofovir) Antiviral Activity against Adenovirus in Patients Correlates with Drug Levels and Viral Sensitivity. Antiviral Research. 90(2). A27–A28. 2 indexed citations
4.
Rice, Amanda D., Mathew M. Adams, Andrew M. Burrage, et al.. (2011). Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans. Viruses. 3(1). 47–62. 56 indexed citations
5.
Lanier, Randall, Lawrence C. Trost, Bernhard Lampert, et al.. (2010). Development of CMX001 for the Treatment of Poxvirus Infections. Viruses. 2(12). 2740–2762. 126 indexed citations
6.
Lanier, E. Randall, Roger G. Ptak, Bernhard Lampert, et al.. (2010). Development of Hexadecyloxypropyl Tenofovir (CMX157) for Treatment of Infection Caused by Wild-Type and Nucleoside/Nucleotide-Resistant HIV. Antimicrobial Agents and Chemotherapy. 54(7). 2901–2909. 35 indexed citations
7.
Lanier, Randall, Bernhard Lampert, Lawrence C. Trost, Merrick R. Almond, & George R. Painter. (2009). Development of Hexadecyloxypropyl Tenofovir (CMX157) for HIV: Potential for Use as a Microbicide and Therapeutic. Antiviral Research. 82(2). A43–A43. 2 indexed citations
8.
Parker, Scott, Merrick R. Almond, Alice Robertson, et al.. (2007). Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model. Antiviral Research. 77(1). 39–49. 82 indexed citations
9.
Painter, George R., Merrick R. Almond, Lawrence C. Trost, et al.. (2007). Evaluation of Hexadecyloxypropyl-9- R -[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. Antimicrobial Agents and Chemotherapy. 51(12). 4538–4538. 3 indexed citations
10.
Painter, George R., Merrick R. Almond, Lawrence C. Trost, et al.. (2007). Evaluation of Hexadecyloxypropyl-9- R -[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. Antimicrobial Agents and Chemotherapy. 51(10). 3505–3509. 58 indexed citations
11.
Tao, W. Andy, Lianming Wu, R. Graham Cooks, et al.. (2001). Rapid Enantiomeric Quantification of an Antiviral Nucleoside Agent (d,l-FMAU, 2‘-Fluoro-5-methyl-β,d,l-arabinofurano- syluracil) by Mass Spectrometry. Journal of Medicinal Chemistry. 44(22). 3541–3544. 42 indexed citations
12.
13.
DiPiro, Joseph T., et al.. (1989). Comparative intraoperative concentrations of two cephalosporins with activity against anaerobic bacteria. Journal of Antimicrobial Chemotherapy. 23(suppl D). 89–95. 3 indexed citations
14.
Lampert, Bernhard & James T. Stewart. (1989). Determination of cocaine and selected metabolites in canine and human serum by reversed-phase high-performance liquid chromatography on coupled cyanopropyl and silica columns. Journal of Chromatography B Biomedical Sciences and Applications. 495. 153–165. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Wardrop Breakdown of academic impact, for papers by Carol Lackman-Smith Breakdown of academic impact, for papers by Boris Feld Breakdown of academic impact, for papers by Nobutoki Takamune Breakdown of academic impact, for papers by Ewald M. Wondrak Breakdown of academic impact, for papers by Arthur Thornton Breakdown of academic impact, for papers by Jianhui Guo Breakdown of academic impact, for papers by Dylan Harris Breakdown of academic impact, for papers by Elcira C. Villarreal Breakdown of academic impact, for papers by Paul W. Keller
Rankless by CCL
2026